Skip to content

The predictive value of UmAlb/UCr for clinical outcomes in patients with infective endocarditis

The predictive value of UmAlb/UCr for clinical outcomes in patients with infective endocarditis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019045
Enrollment
Unknown
Registered
2018-10-23
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective endocarditis

Interventions

Gold Standard:clinical outcome
Index test:UmAlb/UCr

Sponsors

Guangdong General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Males and females, aged more than 18 years; 2. Diagnosed as infective endocarditis; 3. Signature of informed consent;

Exclusion criteria

Exclusion criteria: 1. Cardiogenic shock; 2. Serious liver insufficiency; 3. End-stage renal disease or renal replacement therapy; 4. Life expectancy such as malignant tumor <1 year; 5. Mental disorder or alcohol dependence; 6. Pregnant woman 7. Not suitable to participate the research evaluated by the researchers.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;Multiple adverse events in hospital stay;

Secondary

MeasureTime frame
Multiple adverse events in one year;

Countries

China

Contacts

Public ContactYuanhui Liu

Guangdong General Hospital

lyh0718@126.com+86 13824440637

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026